Daniel W. Lin, MD, discusses the limitations of currently available biomarkers in prostate cancer.
Daniel W. Lin, MD
Advertisement
Articles by Daniel W. Lin, MD
Daniel W. Lin, MD, discusses the importance of biomarker research in prostate cancer.
Daniel W. Lin, MD, discusses the role of genomic markers in prostate cancer.
Advertisement
Latest Updated Articles
Dr. Lin on the Role of Genomic Markers in Prostate CancerPublished: October 27th 2020 | Updated:
Dr. Lin on the Limitations of Current Biomarkers in Prostate CancerPublished: November 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5